NRC Health
NRCHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframePart of the healthcare sector, NRC Health (NRC) is listed under Health Information Services. The company carries a $485.5M market cap, placing it firmly in the small-cap category. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Market Cap
$485.5M
Beta
0.28
P/E (TTM)
91.38
P/E (Fwd)
20.89
EPS (TTM)
$0.24
EPS (Fwd)
$1.05
ROE
42.0%
ROA
8.1%
Cash
$3.3M
Total Debt
$90.4M
Free CF
$20.3M
52W Change
92.0%
Annual Financials
Cash vs Debt
Where NRC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, NRC finished 4.65% above its 150-day moving average ($19.56) and 8.88% above its 200-day moving average ($18.80). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NRC overbought or oversold?
At the October 20, 2026 close, NRC's RSI(14) was 44.6, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
NRC Health carries $90.4M in total debt against $3.3M in cash reserves — debt is roughly 27.2x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $20.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 42.0%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 8.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been relatively flat, moving from $151.6M (2022) to $137.4M (2025).
The relatively low beta of 0.28 suggests NRC is a less volatile holding compared to the broader index. NRC Health carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. At over 50x earnings, NRC carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing NRC.